GlassScriptPhysician profile
Chung Han Lee
NPI 1841432903
$103,570.18
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $16K · 2021: $29K · 2022: $24K · 2023: $6,861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,080 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,980 · Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,080.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,980.00 |
| Food and Beverage | $801.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $53,314.29 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $17,853.28 | 2020-2023 | Keytruda, Welireg |
| Exelixis INC. | $13,117.60 | 2019-2023 | Cabometyx |
| E.R. Squibb & Sons, L.L.C. | $7,519.05 | 2019-2023 | |
| Aveo Pharmaceuticals, INC. | $3,891.31 | 2021-2023 | Fotivda |
| Amgen INC. | $3,554.14 | 2019 | |
| Eisai Co., LTD. | $2,500.00 | 2020 | |
| Pfizer INC. | $1,600.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $123.93 | 2023 | Fasenra |
| Janssen Research & Development, LLC | $67.31 | 2023 | |
| Ironwood Pharmaceuticals, INC | $17.67 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chung Han Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.